StockData

MDxHealth vs Personalis

MDXH and PSNL side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How MDXH and PSNL compare

MDxHealth grew revenue faster over the last twelve months (19.8% versus −13.3% for Personalis).

MDxHealth keeps more of each dollar of sales as profit, with a net margin of −31.1% compared with −154% at Personalis.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricMDXHPSNL
Size and price
Market cap–$1.6B
Share price$0.149$14.80
Change, 1 year−95.9%97.1%
Change, 5 years−98.4%5.8%
Beta (5Y)3.131.24
Employees364260
StockData Score
Total score55
Valuation score00
Growth score3 (better)0
Performance score1 (better)0
Health score15 (better)
Dividend score00
Valuation
P/S–22.7×
P/B–6.7×
FCF yield–−6.4%
Fair value–$3.32
Margin of safety–−345%
Growth
Revenue growth (TTM)19.8% (better)−13.3%
Revenue growth, 5Y average42.3% (better)−2.4%
Profitability
Gross margin64.5% (better)12.7%
Operating margin−13.4% (better)−164%
Net margin−31.1% (better)−154%
FCF margin−3.1% (better)−145%
Return on equity–−50.3%
Return on invested capital–−450%
Financial health
Debt / equity–0.00
Interest coverage−0.6× (better)−536.7×
Current ratio1.085.28 (better)
Altman Z-score–8.99
Piotroski F-score34 (better)
Dividends and buybacks
Buyback yield–−8.5%
Shareholder yield–−8.5%
Ownership
Held by institutions32.3%79.6%
Held by insiders–15.0%
Insider net buying, 12 months$991K (better)−$6.9M
Short interest, % of float–7.4%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.